Nifty
:
22570.35
Sensex
:
74339.44
167.95 (0.75%)
486.50 (0.66%)
Nifty
Sensex
:
:
22570.35
74339.44
167.95 (0.75%)
486.50 (0.66%)

Syncom Formulations (India) Ltd.

Pharmaceuticals & Drugs

Rating :
58/99

BSE: 524470 | NSE: SYNCOMF

NSE BSE
13.75
25-Apr-2024
  • Open
  • High
  • Low
  • Previous Close
  •  14.15
  •  14.25
  •  13.65
  •  14.05
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  2142172
  •  296.28
  •  18.65
  •  5.90

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,319.76
  • 50.02
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,399.68
  • N/A
  • 4.76

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 50.57%
  • 1.28%
  • 44.85%
  • FII
  • DII
  • Others
  • 0.08%
  • 0.00%
  • 3.22%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 4.01
  • 3.76
  • -2.83

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 2.03
  • 10.92
  • -12.18

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.97
  • 12.60
  • -11.72

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.06
  • 42.74
  • 63.36

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.81
  • 0.70
  • 1.16

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.00
  • 24.51
  • 36.34

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Net Sales
65.14
57.38
13.52%
63.84
54.49
17.16%
59.84
51.40
16.42%
60.98
58.23
4.72%
Expenses
57.78
51.48
12.24%
57.43
50.21
14.38%
53.38
47.91
11.42%
55.02
56.19
-2.08%
EBITDA
7.36
5.91
24.53%
6.41
4.28
49.77%
6.46
3.48
85.63%
5.96
2.04
192.16%
EBIDTM
11.30%
10.29%
10.04%
7.86%
10.80%
6.78%
9.77%
3.51%
Other Income
4.55
1.98
129.80%
4.00
2.87
39.37%
1.88
2.98
-36.91%
6.77
5.70
18.77%
Interest
1.08
0.72
50.00%
1.08
0.62
74.19%
1.12
0.50
124.00%
1.29
1.04
24.04%
Depreciation
1.45
1.20
20.83%
0.88
1.18
-25.42%
1.10
0.99
11.11%
1.17
1.01
15.84%
PBT
9.36
5.96
57.05%
8.45
5.36
57.65%
6.11
4.97
22.94%
10.28
5.68
80.99%
Tax
2.36
1.82
29.67%
1.94
1.77
9.60%
1.72
1.10
56.36%
1.81
0.92
96.74%
PAT
7.00
4.15
68.67%
6.51
3.59
81.34%
4.40
3.87
13.70%
8.47
4.76
77.94%
PATM
10.75%
7.22%
10.20%
6.59%
7.35%
7.52%
13.89%
8.17%
EPS
0.07
0.04
75.00%
0.07
0.04
75.00%
0.05
0.04
25.00%
0.09
0.06
50.00%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 23
Mar 22
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Net Sales
249.80
224.25
219.66
184.82
183.90
173.39
151.29
114.95
Net Sales Growth
12.78%
2.09%
18.85%
0.50%
6.06%
14.61%
31.61%
 
Cost Of Goods Sold
151.56
100.65
105.70
102.80
106.54
116.00
101.72
77.54
Gross Profit
98.24
123.60
113.96
82.03
77.36
57.40
49.57
37.41
GP Margin
39.33%
55.12%
51.88%
44.38%
42.07%
33.10%
32.76%
32.54%
Total Expenditure
223.61
204.35
199.63
168.27
167.23
155.18
135.02
104.30
Power & Fuel Cost
-
5.31
4.38
3.01
2.69
2.76
2.40
1.93
% Of Sales
-
2.37%
1.99%
1.63%
1.46%
1.59%
1.59%
1.68%
Employee Cost
-
24.44
20.73
14.45
13.48
13.38
11.35
10.06
% Of Sales
-
10.90%
9.44%
7.82%
7.33%
7.72%
7.50%
8.75%
Manufacturing Exp.
-
44.08
36.93
26.74
27.01
1.55
1.03
0.64
% Of Sales
-
19.66%
16.81%
14.47%
14.69%
0.89%
0.68%
0.56%
General & Admin Exp.
-
15.02
14.06
8.86
8.36
7.54
6.60
6.58
% Of Sales
-
6.70%
6.40%
4.79%
4.55%
4.35%
4.36%
5.72%
Selling & Distn. Exp.
-
14.29
17.32
12.09
8.90
13.72
11.84
7.47
% Of Sales
-
6.37%
7.88%
6.54%
4.84%
7.91%
7.83%
6.50%
Miscellaneous Exp.
-
0.56
0.50
0.31
0.26
0.23
0.08
0.08
% Of Sales
-
0.25%
0.23%
0.17%
0.14%
0.13%
0.05%
0.07%
EBITDA
26.19
19.90
20.03
16.55
16.67
18.21
16.27
10.65
EBITDA Margin
10.48%
8.87%
9.12%
8.95%
9.06%
10.50%
10.75%
9.26%
Other Income
17.20
14.60
11.99
2.79
2.67
1.98
1.12
1.15
Interest
4.57
3.40
1.93
0.33
0.14
0.29
0.47
0.52
Depreciation
4.60
4.54
3.95
3.12
3.00
3.40
2.99
2.83
PBT
34.20
26.56
26.15
15.89
16.20
16.49
13.93
8.45
Tax
7.83
6.50
6.39
5.34
5.75
5.88
4.61
2.79
Tax Rate
22.89%
24.46%
24.42%
33.63%
35.71%
37.62%
33.09%
33.02%
PAT
26.38
20.07
19.79
10.53
10.36
9.76
9.32
5.66
PAT before Minority Interest
26.38
20.07
19.79
10.53
10.36
9.76
9.32
5.66
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
10.56%
8.95%
9.01%
5.70%
5.63%
5.63%
6.16%
4.92%
PAT Growth
61.15%
1.41%
87.94%
1.64%
6.15%
4.72%
64.66%
 
EPS
0.28
0.21
0.21
0.11
0.11
0.10
0.10
0.06

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Shareholder's Funds
256.01
222.22
117.35
108.70
100.22
95.20
87.71
Share Capital
94.00
86.25
78.07
78.07
78.07
78.07
22.30
Total Reserves
162.01
130.94
39.29
30.63
22.16
17.13
65.40
Non-Current Liabilities
8.66
7.76
7.73
6.27
5.62
6.81
8.28
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
2.69
1.71
0.00
0.00
0.00
0.00
0.00
Current Liabilities
113.16
78.26
58.84
65.69
36.66
41.62
28.50
Trade Payables
20.45
13.79
32.27
46.94
19.92
29.35
19.43
Other Current Liabilities
6.91
2.83
5.84
3.67
1.63
0.86
1.72
Short Term Borrowings
83.18
57.79
12.45
5.62
6.08
3.30
2.05
Short Term Provisions
2.62
3.85
8.27
9.46
9.04
8.11
5.30
Total Liabilities
377.83
308.24
183.92
180.66
142.50
143.63
124.49
Net Block
43.40
46.61
55.04
45.85
45.78
50.26
50.47
Gross Block
101.92
100.68
91.98
82.41
80.43
77.18
74.40
Accumulated Depreciation
58.53
54.07
36.94
36.56
34.65
26.93
23.93
Non Current Assets
196.14
168.44
97.38
88.99
58.91
65.54
62.50
Capital Work in Progress
25.59
6.20
0.25
4.72
0.00
0.00
0.00
Non Current Investment
1.84
1.93
35.91
23.37
6.38
9.31
6.74
Long Term Loans & Adv.
2.26
2.25
6.18
15.05
6.75
5.97
5.29
Other Non Current Assets
75.73
64.33
0.00
0.00
0.00
0.00
0.00
Current Assets
181.69
139.80
86.54
91.66
83.59
78.09
61.99
Current Investments
62.26
41.40
0.00
0.00
0.00
0.00
0.00
Inventories
21.20
19.51
10.01
15.47
10.94
9.90
6.07
Sundry Debtors
75.51
67.55
45.99
46.00
31.16
29.42
28.94
Cash & Bank
8.63
0.39
6.52
5.69
6.77
5.28
3.76
Other Current Assets
14.09
2.73
10.50
8.41
34.72
33.50
23.22
Short Term Loans & Adv.
9.63
8.23
13.52
16.10
25.47
27.63
17.28
Net Current Assets
68.53
61.54
27.70
25.98
46.93
36.47
33.49
Total Assets
377.83
308.24
183.92
180.65
142.50
143.63
124.49

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Cash From Operating Activity
10.53
16.33
13.84
24.07
0.08
6.73
5.78
PBT
26.56
26.15
15.88
16.10
16.49
13.93
8.45
Adjustment
-6.11
-7.16
0.71
1.14
2.59
2.36
2.24
Changes in Working Capital
-3.26
3.58
1.29
12.29
-12.51
-5.54
-2.58
Cash after chg. in Working capital
17.18
22.58
17.88
29.53
6.58
10.76
8.11
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-6.65
-6.25
-4.03
-5.35
-5.64
-4.02
-2.34
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
-0.01
-0.10
-0.86
0.00
0.00
Cash From Investing Activity
-44.95
-27.07
-17.68
-22.74
0.74
-4.28
-0.32
Net Fixed Assets
-20.63
-14.65
-5.10
-6.70
-3.25
-2.78
Net Investments
-20.80
-12.37
-7.49
-16.99
2.83
-2.57
Others
-3.52
-0.05
-5.09
0.95
1.16
1.07
Cash from Financing Activity
35.00
8.29
4.67
-2.40
0.68
-0.93
-6.38
Net Cash Inflow / Outflow
0.58
-2.45
0.83
-1.08
1.50
1.52
-0.92
Opening Cash & Equivalents
0.30
2.75
5.69
6.77
5.28
3.76
4.68
Closing Cash & Equivalent
0.88
0.30
6.52
5.69
6.77
5.28
3.76

Financial Ratios

Standalone /

Consolidated
Description
Mar 23
Mar 22
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Book Value (Rs.)
2.72
2.52
1.50
1.39
1.28
1.22
1.12
ROA
5.85%
8.04%
5.78%
6.41%
6.82%
6.95%
4.54%
ROE
8.48%
11.83%
9.32%
9.91%
9.99%
10.19%
6.45%
ROCE
9.68%
13.72%
13.28%
14.72%
15.55%
15.29%
10.00%
Fixed Asset Turnover
2.21
2.28
2.12
2.28
2.20
2.00
1.55
Receivable days
116.42
94.33
90.83
75.88
63.71
70.22
91.86
Inventory Days
33.13
24.52
25.15
25.97
21.92
19.22
19.28
Payable days
62.08
79.52
91.28
73.89
59.55
67.54
70.98
Cash Conversion Cycle
87.47
39.33
24.70
27.96
26.08
21.90
40.17
Total Debt/Equity
0.32
0.27
0.11
0.05
0.06
0.03
0.02
Interest Cover
8.81
14.58
48.48
119.10
54.58
30.75
17.10

Annual Reports:

FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015

News Update:


  • Syncom Formulations - Quarterly Results
    14th Feb 2024, 17:28 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.